A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2007
11/15/2007	US20070264201 Contrast Agents
11/15/2007	US20070264199 Magnetic nanoparticle composition and methods for using the same
11/15/2007	US20070264198 Tumor necrosis agent
11/15/2007	US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007	US20070264196 Modulators of ATP-binding cassette transporters
11/15/2007	US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007	DE102006021495A1 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit Use of perfluoroalkyl-containing metal complexes as contrast agents for the diagnosis of Alzheimer's disease
11/15/2007	CA2656824A1 Men1 is a marker and therapeutic target for breast and prostate cancer
11/14/2007	EP1854489A1 Method of measuring physiological function
11/14/2007	EP1853318A1 Layered nanoparticles
11/14/2007	EP1483262B1 Coumarines useful as biomarkers
11/14/2007	EP1251780B1 Luminescent in vivo glucose measurement
11/14/2007	EP1191894B1 System for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response
11/14/2007	EP0837641B1 Container for hyperpolarized noble gases having a surface coated with a modified polymer
11/14/2007	CN101072591A Pet and magnetic resonance for screening alzheimer's diseasetherapeutics
11/14/2007	CN101072590A Dmbt1 as a clinical marker and uses thereof
11/14/2007	CN101069747A Method for setting acetic-acid gastric ulcer disease recurrence model
11/13/2007	US7294334 Methods and compositions to treat myocardial conditions
11/08/2007	WO2007127958A2 Detection and imaging of target tissue
11/08/2007	WO2007127603A2 Apparatus and methods for pain relief using ultrasound energized polymers
11/08/2007	WO2007126967A2 Atmospheric pressure microwave plasma treated porous membranes
11/08/2007	WO2007109121A3 A zebrafish model for assessing gastrointestinal motility
11/08/2007	WO2007088129A3 Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging
11/08/2007	WO2007050581A3 An albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
11/08/2007	US20070260156 Method and apparatus for examining tissue for predefined target cells, particularly cancerous cells, and a probe useful in such method and apparatus
11/08/2007	US20070258908 Detection and imaging of target tissue
11/08/2007	US20070258907 Polymer-coated paramagnetic particles
11/08/2007	US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007	US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/08/2007	US20070258904 Optical Imaging Contrast Agents
11/08/2007	US20070258903 Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
11/08/2007	US20070258902 Method for Assessing Atherosclerosis
11/08/2007	US20070258901 Capsules Containing Transiently Transfected Cells, Method for Preparing Same and Uses Thereof
11/08/2007	US20070258900 Blood Flow Assessment of Clostridial Toxin Applications
11/08/2007	US20070258899 Diagnostic and therapeutic agents
11/08/2007	US20070258898 Markers for addiction
11/08/2007	US20070258896 Contrast Agents In Medical Imaging
11/08/2007	US20070258895 Estrogen Receptors and Methods of Use
11/08/2007	US20070258889 Novel nanoparticles and use thereof
11/08/2007	US20070258888 Contrast Agent for Medical Imaging Techniques and Usage Thereof
11/08/2007	US20070258886 Methods for assessing cell labeling
11/08/2007	CA2650616A1 Hepatitis c virus infection biomarkers
11/08/2007	CA2650375A1 Genetic adjuvants for viral vaccines
11/08/2007	CA2647871A1 Method and system for determining whether a drug will be effective on a patient with a disease
11/07/2007	EP1852107A1 Magnetic nanoparticles compositions and uses thereof
11/07/2007	EP1850746A2 Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto
11/07/2007	EP0979071B1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
11/07/2007	CN101068577A Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy
11/07/2007	CN101068576A Imaging infection with compounds that bind to thymidine kinase
11/07/2007	CN100347562C 磁共振研究方法 Magnetic Resonance Research Methods
11/07/2007	CN100346835C Acute early young granulocytic leakemia transplantation mouse model of PLZF-RARa and PLZF-RARa/RARa-PLZF
11/06/2007	US7291710 Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
11/06/2007	US7291454 Comprises antisense olignucleotides, ribozymes, DNA and guide sequences; animal models; genetic engineering; for use in drug screening
11/06/2007	CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/01/2007	WO2007124131A2 Hybrid nanomaterials as multimodal imaging contrast agents
11/01/2007	WO2007123777A2 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
11/01/2007	WO2007122823A1 Tumor target cell capable of producing vector
11/01/2007	WO2007122226A2 Patch and uses thereof
11/01/2007	WO2006066118A3 Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment
11/01/2007	US20070255169 Clean margin assessment tool
11/01/2007	US20070255140 Echogenic coatings with overcoat
11/01/2007	US20070255117 Enhanced ultrasound detection with temperature-dependent contrast agents
11/01/2007	US20070254833 Compositions and methods for treating diverticular disease
11/01/2007	US20070254022 Cationic liposome delivery of taxanes to angiogenic blood vessels
11/01/2007	US20070254020 Molecular communication system and molecular communication method
11/01/2007	US20070253910 Cellular labeling and quantification for nuclear magnetic resonance techniques
11/01/2007	US20070253905 Abeta42 LOWERING AGENTS
11/01/2007	US20070253904 administering a diabetic patient a formulation containing an aryl hydrocarbon receptor nuclea rtranslocator (ARNT) polypeptide to treat diabetes type I, diabetes type II, impaired glucose tolerance, insulin resistance, and beta cell dysfunction
11/01/2007	US20070253903 Method for (Two-Step) Dosing and Dosage Finding
11/01/2007	US20070253901 Atherosclerosis genes and related reagents and methods of use thereof
11/01/2007	US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007	US20070253899 Dual Function Polymer Micelles
11/01/2007	CA2650266A1 Patch and uses thereof
10/2007
10/31/2007	EP1849482A1 Multimodally altered cells as a form for administering active substances and as diagnostic particles
10/31/2007	EP1848778A2 De novo synthesis of bacteriochlorins
10/31/2007	EP1848466A2 Mri contrast agents for diagnosis and prognosis of tumors
10/31/2007	EP1848465A2 Steady state perfusion methods
10/31/2007	EP1848464A1 Compositions and methods for multimodal imaging
10/31/2007	EP1848429A1 Pharmaceutical agents containing fluoroalkylated metal complexes and epothilone
10/31/2007	EP1755584A4 Treatment of myopia
10/31/2007	EP1416846B1 Method and device for determining a characteristic value relating to the blood circulation of modified tissue regions in organs of living beings
10/31/2007	EP1387637B1 Apparatus for measuring local physical parameters in a fluid filled cavity
10/31/2007	CN101065153A Radiopaque polymeric stents
10/31/2007	CN101065152A Upar-targeting contrast agents
10/31/2007	CN101062423A Gas emulsion type Ultrasound Contrast Agent microspheres and the preparing method thereof
10/31/2007	CN101062422A The coupling substrate between magnetic resonance imaging contrast agent based on metal fullerene and antibody and the detecting technology
10/31/2007	CN101062421A Magnetic resonance imaging contrast agent having bone tissue targeting detection based on metal fullerene and the preparation thereof
10/31/2007	CN101062420A Pharmacodynamics experiment method of adenosine medicine
10/31/2007	CN101062016A Immune micro-liposomal used in the cancer developing, diagnosing and treating and the application thereof
10/31/2007	CN100345821C Process for preparation of iopamidol and new intermediates therein
10/31/2007	CN100345548C Drug for treating fractures
10/30/2007	US7288267 Bioadhesive nanoparticulate compositions having cationic surface stabilizers
10/30/2007	US7288261 Administering to a mammal, an immunogenically effective amount of an Mtb immunogenic protein vaccine
10/30/2007	US7288244 Determining vulnerable plaque in blood vessels
10/30/2007	US7287646 Diagnosis and treatment of cervical and bladder cancer; improved photochemotherapeutic properties; antineoplastic agents
10/30/2007	US7287391 Automated modular hyperpolarizers and related devices and methods
10/30/2007	US7287390 Optical pumping modules, polarized gas blending and dispensing systems, and automated polarized gas distribution systems and related devices and methods
10/30/2007	CA2171218C Metallospheres and superclusters
10/25/2007	WO2007121453A2 2-hydroxy-1-oxo 1,2 dihydro isoquinoline chelating agents
10/25/2007	WO2007120830A2 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 354